全文获取类型
收费全文 | 31707篇 |
免费 | 1591篇 |
国内免费 | 295篇 |
专业分类
耳鼻咽喉 | 232篇 |
儿科学 | 707篇 |
妇产科学 | 763篇 |
基础医学 | 3545篇 |
口腔科学 | 1031篇 |
临床医学 | 2608篇 |
内科学 | 8708篇 |
皮肤病学 | 670篇 |
神经病学 | 2794篇 |
特种医学 | 1032篇 |
外国民族医学 | 1篇 |
外科学 | 4888篇 |
综合类 | 203篇 |
一般理论 | 5篇 |
预防医学 | 1490篇 |
眼科学 | 392篇 |
药学 | 1747篇 |
中国医学 | 79篇 |
肿瘤学 | 2698篇 |
出版年
2023年 | 248篇 |
2022年 | 526篇 |
2021年 | 867篇 |
2020年 | 556篇 |
2019年 | 832篇 |
2018年 | 990篇 |
2017年 | 842篇 |
2016年 | 808篇 |
2015年 | 897篇 |
2014年 | 1129篇 |
2013年 | 1560篇 |
2012年 | 2371篇 |
2011年 | 2329篇 |
2010年 | 1369篇 |
2009年 | 1231篇 |
2008年 | 2130篇 |
2007年 | 2031篇 |
2006年 | 1899篇 |
2005年 | 1901篇 |
2004年 | 1754篇 |
2003年 | 1606篇 |
2002年 | 1468篇 |
2001年 | 354篇 |
2000年 | 268篇 |
1999年 | 296篇 |
1998年 | 273篇 |
1997年 | 234篇 |
1996年 | 192篇 |
1995年 | 226篇 |
1994年 | 185篇 |
1993年 | 163篇 |
1992年 | 178篇 |
1991年 | 138篇 |
1990年 | 184篇 |
1989年 | 139篇 |
1988年 | 122篇 |
1987年 | 108篇 |
1986年 | 123篇 |
1985年 | 113篇 |
1984年 | 113篇 |
1983年 | 67篇 |
1982年 | 77篇 |
1981年 | 51篇 |
1980年 | 65篇 |
1979年 | 70篇 |
1978年 | 39篇 |
1977年 | 45篇 |
1975年 | 34篇 |
1974年 | 40篇 |
1972年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
G Sardella G Biondi-Zoccai F Fedele 《Archives of internal medicine》2012,172(13):1044; author reply 1044-1044; author reply 1045
992.
Lippi G 《Archives of internal medicine》2012,172(4):373; author reply 374-373; author reply 375
993.
994.
Alessandro Morandi MD MPH Jessica McCurley MS Eduard E. Vasilevskis MD Donna M. Fick PhD Giuseppe Bellelli MD Patricia Lee MLS James C. Jackson PsyD Susan D. Shenkin MRCP Msc MarcoTrabucchi MD John Schnelle PhD Sharon K. Inouye MD MPH E. Wesley Ely MD MPH Alasdair MacLullich MRCP PhD 《Journal of the American Geriatrics Society》2012,60(11):2005-2013
995.
996.
997.
Breccia M Mazzarella L Bagnardi V Disalvatore D Loglisci G Cimino G Testi AM Avvisati G Petti MC Minotti C Latagliata R Foà R Pelicci PG Lo-Coco F 《Blood》2012,119(1):49-54
We investigated whether body mass index (BMI) correlates with distinct outcomes in newly diagnosed acute promyelocytic leukemia (APL). The study population included 144 patients with newly diagnosed and genetically confirmed APL consecutively treated at a single institution. All patients received All-trans retinoic acid and idarubicin according to the GIMEMA protocols AIDA-0493 and AIDA-2000. Outcome estimates according to the BMI were carried out together with multivariable analysis for the risk of relapse and differentiation syndrome. Fifty-four (37.5%) were under/normal weight (BMI < 25), whereas 90 (62.5%) patients were overweight/obese (BMI ≥ 25). An increased BMI was associated with older age (P < .0001) and male sex (P = .02). BMI was the most powerful predictor of differentiation syndrome in multivariable analysis (odds ratio = 7.24; 95% CI, 1.50-34; P = .014). After a median follow-up of 6 years, the estimated cumulative incidence of relapse at 5 years was 31.6% (95% CI, 22.7%-43.8%) in overweight/obese and 11.2% (95% CI, 5.3%-23.8%) in underweight/normal weight patients (P = .029). Multivariable analysis showed that BMI was an independent predictor of relapse (hazard ratio = 2.45, 95% CI, 1.00-5.99, in overweight/obese vs under/normal weight patients, P = .049). An increased BMI at diagnosis is associated with a higher risk of developing differentiation syndrome and disease relapse in APL patients treated with AIDA protocols. 相似文献
998.
Tiacci E Schiavoni G Forconi F Santi A Trentin L Ambrosetti A Cecchini D Sozzi E Francia di Celle P Di Bello C Pulsoni A Foà R Inghirami G Falini B 《Blood》2012,119(1):192-195
Hairy cell leukemia (HCL) is a distinct clinicopathologic entity that responds well to purine analogs but is sometimes difficult to differentiate from HCL-like disorders (e.g., splenic marginal zone lymphoma and HCL variant). We recently identified the BRAF-V600E mutation as the disease-defining genetic event in HCL. In this study, we describe a new, simple, and inexpensive test for genetics-based diagnosis of HCL in whole-blood samples that detects BRAF-V600E through a sensitive allele-specific PCR qualitative assay followed by agarose-gel electrophoresis. This approach detected BRAF-V600E in all 123 leukemic HCL samples investigated containing as few as 0.1% leukemic cells. BRAF-V600E was detected at different time points during the disease course, even after therapy, pointing to its pivotal role in HCL pathogenesis and maintenance of the leukemic clone. Conversely, 115 non-HCL chronic B-cell neoplasms, including 79 HCL-like disorders, were invariably negative for BRAF-V600E. This molecular assay is a powerful tool for improving the diagnostic accuracy in HCL. 相似文献
999.
Littera R Orrù N Caocci G Sanna M Mulargia M Piras E Vacca A Giardini C Orofino MG Visani G Bertaina A Giorgiani G Locatelli F Carcassi C La Nasa G 《British journal of haematology》2012,156(1):118-128
In a study conducted on 114 patients undergoing unrelated donor haematopoietic stem cell transplantation (HSCT) for thalassaemia, we observed that the lack of activating killer immunoglobulin-like receptors (KIRs) on donor natural killer (NK) cells significantly increased the risk of graft-versus-host disease (GvHD) [hazard risk (HR) 4.2, 95% confidence interval (CI) 1.7-10.1, P = 0.002] and transplantation-related mortality (HR 4.7, 95% CI 1.6-14.2, P = 0.01). The risk of GvHD furthermore increased when recipients heterozygous for HLA-C KIR ligand groups (C1/C2) were transplanted from donors completely lacking activating KIRs (HR 6.1, 95% CI 1.9-19.2, P = 0.002). We also found that the risk of rejection was highest when the recipient was homozygous for the C2 HLA-KIR ligand group and the donor carried two or more activating KIRs (HR 6.8, 95% CI 1.9-24.4, P = 0.005). By interpolating the number of donor activating KIRs with recipient HLA-C KIR ligands, we created an algorithm capable of stratifying patients according to the immunogenetic risk of complications following unrelated HSCT. In clinical practice, this predictive tool could serve as an important supplement to clinical judgement and decision-making. 相似文献